Arcturus Boosts Cash, Appoints New CFO to Accelerate RNA Therapeutics
Arcturus Therapeutics bolsters its RNA‑therapeutics pipeline with a new CFO and a directed share issuance, strengthening its balance sheet and positioning for growth.
- ARCTURUS THERAPEUTICS HOLDIN
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read